Close Menu

Integrated Diagnostics

People in the News

Premium

Steve Spotts becomes chief commercial officer of Swift Biosciences; Integrated Diagnostics adds Jay Moyes as independent director; Qiagen supervisory board proposes Vera Kallmeyer and Elizabeth Tallett for election.

Movers & Shakers

Premium

Kenneth Fang, Alf Lindberg, Catherin Derasp

Pairings

Premium

Kenneth Fang, Robert Maki, George Demetri, Judy Garber, Mark Robson

A number of prominent proteomics-based diagnostics developers were recipients of the grant and tax credit awards, which are being provided by the IRS through the Patient Protection and Affordable Care Act's Qualifying Therapeutic Discovery Project Program.

Movers & Shakers

Premium

Gregory Critchfield, Ian Pike, Rainer Metternich

Pairings

Premium

Gregory Critchfield

Paired Ends

Premium

Paul Billings, Robert Wall, Cliff Reid, Michael Rubin, David Baltimore, Gregory Critchfield, David Barker, Jim Heath, Lee Hood, Patrizia Luchetta, Albert Luderer, Arnold Oronsky, Subra Suresh

The company next year plans to launch a 1,000-patient verification trial for its lung cancer protein biomarker panel, with trials for its Alzheimer's disease panel likely to follow, said an official.

The company is leveraging the research of Lee Hood and using genomics and proteomics technologies to develop tests for a broad range of diseases.

Movers & Shakers

Premium

Collin D'Silva, Albert Luderer, Timm Jessen, Dave Lemus, Robert Huber, Ingo Köhler, Berthold Hinzen, Andre Schmutte

Pages

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.